47045-QPA-C-IGAD-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative xml:lang="en">HIV/TB - Africa - Multicountry Eastern Africa IGAD (01-Oct-2016-31-Mar-2019)</narrative> Multicountry Eastern Africa IGAD, TB/HIV, Intergovernmental Authority on Development (IGAD)This program has the following goals: To contribute to the reduction of HIV/AIDS and TB related morbidity and mortality among cross border and mobile populations including refugees in IGAD member countries. To contribute to the reduction of new HIV infections and TB incidence among cross border and mobile populations including refugees in IGAD member countries. The objectives of this program are: To enhance the regional coordination and collaboration mechanisms for health service delivery and monitoring results in the IGAD region. To improve TB and HIV service access and utilization among the refugee populations in the IGAD region The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development Intergovernmental Authority on Development Intergovernmental Authority on Development The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Grant Management Division George, SAKVARELIDZE Fund Portfolio Manager +41 58 791 1700 george.sakvarelidze@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS Tuberculosis and Malaria Communications Web Team +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Multicountry Eastern Africa IGAD TB/HIV -2303645.00 Global Fund Commitment to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 7082622.00 Global Fund Commitment to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) -2852.00 Global Fund Commitment to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 5196841.00 Global Fund Commitment to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) -236245.00 Global Fund Commitment to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 739408.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 17000.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 20500.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 25920.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 428976.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 1035066.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 990703.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 1704760.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 1000698.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 133000.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 12000.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 557853.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 846998.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 27000.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) -2852.00 Global Fund disbursement to QPA-C-IGADP01. Intergovernmental Authority on Development (IGAD) The Global Fund to Fight AIDS, Tuberculosis and Malaria 634300.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 18240.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 1009265.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) 537886.00 Global Fund disbursement to QPA-C-IGADP01. Global Fund to Fight AIDS, Tuberculosis and Malaria Intergovernmental Authority on Development (IGAD) <narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative> An overview of a grant over it's lifetime. <narrative xml:lang="en">Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative xml:lang="en">Coverage / Output indicators targets and results for QPA-C-IGADP01</narrative> <narrative xml:lang="en">KP-other 1: Number of health care providers received training on HIV testing, PMTCT or provision of Integrated HIV & reproductive health services in the refugee camps</narrative> <narrative xml:lang="en">HSS- other 3: Number of community health workers received training on health promotion and disease prevention (including TB case detection and referral)</narrative> <narrative xml:lang="en">HSS- other 2: Number of health care providers received training on TB care and prevention</narrative> <narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> <narrative xml:lang="en">Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results</narrative> <narrative xml:lang="en">Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> <narrative xml:lang="en">Percentage of health facilities reporting no stock-outs of essential drugs</narrative> <narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> <narrative xml:lang="en">HSS- other 1: Number of health professionals received training on national guidelines on HIV treatment and care</narrative> <narrative xml:lang="en">Outcome indicators targets and results for QPA-C-IGADP01</narrative> <narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative> <narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative> <narrative xml:lang="en">Percentage of adults and children with HIV, known to be on treatment 12 months after initiation of antiretroviral therapy</narrative> <narrative xml:lang="en">Impact indicators targets and results for QPA-C-IGADP01</narrative> <narrative xml:lang="en">Percentage of antenatal care attendees who were positive for syphilis</narrative>